The discovery of the HFE gene has lead to considerable improvement in the u
nderstanding and the management of genetic hemochromatosis. More than 90 %
of well-defined patients are homozygous for the C282 Y mutation, and geneti
c testing has become an important diagnostic tool. The significance of the
other mutations in the HFE gene remain controversial : only C282Y / H63D co
mpound heterozygotes could present with a phenotype compatible with hemochr
omatosis, but with a mild expression and a low penetrance. The link between
iron overload and HFE mutation is explained by the interaction between HFE
protein, beta-2-microglobulin and transferrin receptor; which is abolished
by the C282Y mutation, but is not yet fully understood.